FIELD: chemistry.
SUBSTANCE: invention relates to a 2,3-dihydro-1H-pyrrolysin-7-formamide derivative as a nucleoprotein inhibitor.
EFFECT: new compounds with formula (II) have been obtained, which can be used in the preparation of a drug for the treatment of diseases associated with HBV.
20 cl, 12 tbl, 39 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NITROIMIDAZOLE DERIVATIVE AGAINST PULMONARY TUBERCULOSIS | 2016 |
|
RU2675622C1 |
| PYRIDOPYRIMIDINE COMPOUNDS ACTING AS DOUBLE INHIBITORS OF mTORC 1/2 | 2018 |
|
RU2771201C2 |
| BICYCLIC COMPOUND AS RIP-1 KINASE INHIBITOR AND ITS USE | 2020 |
|
RU2800652C2 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
| PYRIMIDINES AND THEIR OPTIONS, AND THEIR APPLICATION | 2017 |
|
RU2760733C2 |
| CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| DERIVATIVE WITH CONDENSED RING AS A RECEPTOR INHIBITOR | 2018 |
|
RU2748993C1 |
| IMIDAZOPIRASOTHINES AS PDE1 INHIBITORS | 2016 |
|
RU2712219C2 |
| TRICYCLIC COMPOUNDS AFFECTING CRBN PROTEINS | 2019 |
|
RU2801068C2 |
